Log in to save to my catalogue

TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2

TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4682084

TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2

About this item

Full title

TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2015-12, Vol.5 (1), p.17936-17936, Article 17936

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The fully human monoclonal antibody KMTR2 acts as a strong direct agonist for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 2 (TRAIL-R2), which is capable of inducing apoptotic cell death without cross-linking. To investigate the mechanism of direct agonistic activity induced by KMTR2, the crystal structure of the extrace...

Alternative Titles

Full title

TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4682084

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4682084

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep17936

How to access this item